title: Kinase inhibition in rheumatoid arthritis: a big advance?
authors.affiliation: Department of Clinical Immunology and Rheumatology and Immunogenomics and Inflammation Research Unit, University of Lyon, Edouard Herriot Hospital, 69437 Lyon, France. miossec@univ-lyon1.fr
authors.forename: Pierre
authors.initials: P
authors.lastname: Miossec
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D053612:Janus Kinases / Q000037:antagonists & inhibitors*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D010880:Piperidines; D011743:Pyrimidines / Q000008:administration & dosage*; D011758:Pyrroles / Q000008:administration & dosage*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D010880:Piperidines; D011743:Pyrimidines; D011758:Pyrroles; D014409:Tumor Necrosis Factor-alpha; C479163:tofacitinib; D053612:Janus Kinases; D008727:Methotrexate